Aimmune Therapeutics, Inc. Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Aimmune Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aimmune Therapeutics, Inc. for March 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Option Exercise | A | 34.07 | 56,250 | 1,916,438 | 56,250 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Barrowcliffe Susan E. | General Manager, Eu ... | Grant | A | 0.00 | 9,375 | 0 | 9,375 | 0 to 9.4 K |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Knapp Jeffrey H | Chief Operating Off ... | Option Exercise | A | 34.07 | 56,250 | 1,916,438 | 56,250 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Knapp Jeffrey H | Chief Operating Off ... | Grant | A | 0.00 | 9,375 | 0 | 12,151 | 2.8 K to 12.2 K (+337.72 %) |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | A | 34.07 | 41,250 | 1,405,388 | 41,250 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Grant | A | 0.00 | 6,875 | 0 | 7,004 | 129 to 7 K (+5,329.46 %) |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 12.95 | 1,648 | 21,342 | 66,945 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | M | 19.63 | 1,875 | 36,806 | 67,500 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Option Exercise | A | 34.07 | 75,000 | 2,555,250 | 75,000 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 36.60 | 700 | 25,618 | 32,500 | 33.2 K to 32.5 K (-2.11 %) |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 35.52 | 948 | 33,674 | 33,200 | 34.1 K to 33.2 K (-2.78 %) |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 12.95 | 1,648 | 21,342 | 34,148 | 32.5 K to 34.1 K (+5.07 %) |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Sell | S | 37.00 | 1,875 | 69,375 | 32,500 | 34.4 K to 32.5 K (-5.45 %) |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Buy | M | 19.63 | 1,875 | 36,806 | 34,375 | 32.5 K to 34.4 K (+5.77 %) |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Sheehy Douglas T. | See Remarks | Grant | A | 0.00 | 32,500 | 0 | 32,500 | 0 to 32.5 K |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Option Exercise | A | 34.07 | 56,250 | 1,916,438 | 56,250 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | ADELMAN DANIEL C MD | Chief Medical Offic ... | Grant | A | 0.00 | 9,375 | 0 | 9,375 | 0 to 9.4 K |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Option Exercise | A | 34.07 | 56,250 | 1,916,438 | 56,250 | |
Mar 06 2018 | AIMT | Aimmune Therapeuti ... | BJERKHOLT ERIC | Chief Financial Off ... | Grant | A | 0.00 | 9,375 | 0 | 17,500 | 8.1 K to 17.5 K (+115.38 %) |
Mar 05 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Option Exercise | M | 3.02 | 1,807 | 5,461 | 105,436 | |
Mar 05 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Sell | S | 33.10 | 1,807 | 59,812 | 129 | 1.9 K to 129 (-93.34 %) |
Mar 05 2018 | AIMT | Aimmune Therapeuti ... | Rozenman Mary M. | See Remarks | Buy | M | 3.02 | 1,807 | 5,461 | 1,936 | 129 to 1.9 K (+1,400.78 %) |